Caldwell Trust CO Krystal Biotech, Inc. Transaction History
Caldwell Trust CO
- $1.07 Trillion
- Q3 2025
A detailed history of Caldwell Trust CO transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Caldwell Trust CO holds 250 shares of KRYS stock, worth $51,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$51,540
Previous $34.4 Million
28.42%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
328Shares Held
24.5MCall Options Held
249KPut Options Held
613K-
Black Rock Inc. New York, NY3.95MShares$814 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.79MShares$576 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.78MShares$573 Million6.7% of portfolio
-
State Street Corp Boston, MA1.4MShares$288 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.02MShares$210 Million10.94% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.29B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...